Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor

CANTOS reported reduced secondary atherothrombotic events in patients with residual inflammatory risk treated with the inhibitory anti-IL-1β antibody, Canakinumab. Yet, mechanisms that underlie this benefit remain elusive. Recent work has implicated formation of neutrophil extracellular traps (NETos...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberale, Luca, Holy, Erik W., Akhmedov, Alexander, Bonetti, Nicole R., Nietlispach, Fabian, Matter, Christian M., Mach, François, Montecucco, Fabrizio, Beer, Jürg H., Paneni, Francesco, Ruschitzka, Frank, Libby, Peter, Lüscher, Thomas F., Camici, Giovanni G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947515/
https://www.ncbi.nlm.nih.gov/pubmed/31779200
http://dx.doi.org/10.3390/jcm8122072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947515/
https://www.ncbi.nlm.nih.gov/pubmed/31779200
http://dx.doi.org/10.3390/jcm8122072

Ejemplares similares